Autoimmune Limbic Encephalitis

Authors

  • Cristiana Barbosa Serviço de Medicina Interna, Serviço de neurologia, Serviço de neurorradiologia, Centro Hospitalar Tondela Viseu - Unidade de Viseu , Viseu, Portugal
  • Luís Patrão Serviço de Medicina Interna, Serviço de neurologia, Serviço de neurorradiologia, Centro Hospitalar Tondela Viseu - Unidade de Viseu , Viseu, Portugal
  • Victor Bettencourt Serviço de Medicina Interna, Serviço de neurologia, Serviço de neurorradiologia, Centro Hospitalar Tondela Viseu - Unidade de Viseu , Viseu, Portugal
  • Sara Pereira Serviço de Medicina Interna, Serviço de neurologia, Serviço de neurorradiologia, Centro Hospitalar Tondela Viseu - Unidade de Viseu , Viseu, Portugal
  • Joana Domingues Serviço de Medicina Interna, Serviço de neurologia, Serviço de neurorradiologia, Centro Hospitalar Tondela Viseu - Unidade de Viseu , Viseu, Portugal
  • António Garrido Serviço de Medicina Interna, Serviço de neurologia, Serviço de neurorradiologia, Centro Hospitalar Tondela Viseu - Unidade de Viseu , Viseu, Portugal

DOI:

https://doi.org/10.24950/rspmi.965

Keywords:

Autoimmune Diseases, Limbic Encephalitis

Abstract

Limbic encephalitis is a rare but increasingly recognized disorder. The sudden onset of symptoms such as confusion, cognitive impairment, irritability, depression, hallucinations, is one of
the main characteristics. It is an inflammatory disease involving
the temporal lobes, which explains the frequency of seizures.
We report the case of a 27-year-old man, presenting hyperosmolar syndrome (owing to new onset diabetes mellitus), acute
confusional state and sudden onset of seizures. Several diagnostic hypotheses were raised: infectious meningoencephalitis,
autoimmune encephalitis, and metabolic encephalopathy. Despite treatment (antibiotics, correction of hyperosmolar state
and anticonvulsant therapy), continuous cognitive deterioration
and seizures persisted. We raised the hypothesis of an autoimmune limbic encephalitis by anti-GAD antibodies and treated
with human immunoglobulin. There was a dramatic improvement, corroborating the diagnosis (along with imaging findings). Although difficult to diagnose, limbic encephalitis should
be considered when studying acute confusional states with
psychiatric symptoms and seizures. Clinical suspicion and early
treatment are essential for therapeutic success.

Downloads

Download data is not yet available.

References

Brierley JB, Corsellis JAN, Hierons R, Nevin S. Subacute encephalitis of later adult life. Mainly affecting the limbic areas. Brain.

;83:357-68.

Finelli PF. Autoimmune limbic encephalitis with GAD antibodies. Neurohospitalist. 2011;1:178-81.

Buckley C, Oger J, Clover L, Tüzün E, Carpenter K, Jackson M, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50:73-8.

Leypoldt F, Wandinger KP, Bien C, Dalmau J. Autoimmune encephalitis. Eur Neurol Rev. 2012;8:31.

Tuzun E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007;13:261-71.

Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123:1481-94.

Mark M. A New adult onset temporal lobe epilepsy linked to limbic encephalitis. Neurol Today. 2007;7:4-6.

Caselli RJ, Drazkowski JF, Wingerchuk DM. Autoimmune Encephalopathy. Mayo Clin Proc. 2010;85:878-80.

Derry C, Wilkie M, Al-Shahi Salman R, Davenport R. Autoimmune limbic encephalitis. Clin Med. 2011;11:176-8.

Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, et al. Spectrum of neurological syndromes associated with

glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131:2553-63.

Errichiello L, Perruolo G, Pascarella A, Formisano P, Minetti C, Striano S, et al. Autoantibodies to glutamic acid decarboxylase

(GAD) in focal and generalized epilepsy: A study on 233 patients. J Neuroimmunol. 2009;211:120-3.

Sharma A, Dubey D, Sawhney A, Janga K. GAD65 Positive autoimmune case report and review of literature. J Clin Med Res.

;4:424-8.

Kanellakopoulou K, Pagoulatou A, Stroumpoulis K, Vafiadou M, Kranidioti H, Giamarellou H, et al. Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect. J Antimicrob Chemother. 2008;61:1328-31.

Bak T, Antoun N, Balan K, Hodges J. Memory lost, memory regained: neuropsychological findings and neuroimaging in two

cases of paraneoplastic limbic encephalitis with radically different outcomes. J Neurol Neurosurg Psychiatry. 2001;71:40-7.

Akman CI, Patterson MC, Rubinstein A, Herzog R. Limbic encephalitis associated with anti-GAD antibody and common variable

immune deficiency. Dev Med Child Neurol. 2009;51:563-7.

Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B et al. Non-paraneoplastic limbic encephalitis associated with

anti-glutamic acid decarboxylase antibodies. J Neuroimmunol. 2008;199:155-9.

Irani SR. Vincent A. Autoimmune encephalitis — new awareness, challenging questions. Discov Med. 2011;11:449-58.

Sharp M, Javidan M. Immunomodulation in adult epilepsy: the role of IVIG. Can J Neurol Sci. 2012; 39:584-91.

Additional Files

Published

2015-12-31

How to Cite

1.
Barbosa C, Patrão L, Bettencourt V, Pereira S, Domingues J, Garrido A. Autoimmune Limbic Encephalitis. RPMI [Internet]. 2015 Dec. 31 [cited 2024 Dec. 18];22(4):215-8. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/965

Most read articles by the same author(s)